These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 29788161)

  • 21. Large-scale preparation and in vitro characterization of biologically active human placental (20 and 22K) and pituitary (20K) growth hormones: placental growth hormones have no lactogenic activity in humans.
    Solomon G; Reicher S; Gussakovsky EE; Jomain JB; Gertler A
    Growth Horm IGF Res; 2006; 16(5-6):297-307. PubMed ID: 17010651
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The conformation of the poly(ethylene glycol) chain in mono-PEGylated lysozyme and mono-PEGylated human growth hormone.
    Pai SS; Hammouda B; Hong K; Pozzo DC; Przybycien TM; Tilton RD
    Bioconjug Chem; 2011 Nov; 22(11):2317-23. PubMed ID: 21950579
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Linear and branched bicin linkers for releasable PEGylation of macromolecules: controlled release in vivo and in vitro from mono- and multi-PEGylated proteins.
    Zhao H; Yang K; Martinez A; Basu A; Chintala R; Liu HC; Janjua A; Wang M; Filpula D
    Bioconjug Chem; 2006; 17(2):341-51. PubMed ID: 16536464
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Purification and analysis of mono-PEGylated HSA by hydrophobic interaction membrane chromatography.
    Shang X; Wittbold W; Ghosh R
    J Sep Sci; 2013 Dec; 36(23):3673-81. PubMed ID: 24106126
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Site-specific PEGylation of engineered cysteine analogues of recombinant human granulocyte-macrophage colony-stimulating factor.
    Doherty DH; Rosendahl MS; Smith DJ; Hughes JM; Chlipala EA; Cox GN
    Bioconjug Chem; 2005; 16(5):1291-8. PubMed ID: 16173810
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Preparation and characterization of mono PEGylated recombinant human interferon omega].
    Liu H; Cheng YG; Pan HC; Xu B; Peng L; Yang HT; Guo W
    Yao Xue Xue Bao; 2012 Mar; 47(3):393-8. PubMed ID: 22645765
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Purification, characterization and plasma half-life of PEGylated soluble recombinant non-HA-binding CD44.
    Pink A; Kallastu A; Turkina M; Skolnaja M; Kogerman P; Päll T; Valkna A
    BioDrugs; 2014 Aug; 28(4):393-402. PubMed ID: 24567264
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Integrated solid-phase synthesis and purification of PEGylated protein.
    Shang X; Yu D; Ghosh R
    Biomacromolecules; 2011 Jul; 12(7):2772-9. PubMed ID: 21657227
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Separation and purification of PEGylated rhG-CSF by two-step ion-exchange chromatography].
    Chen T; Yun Q; Bi JX; Ma GH; Su ZG
    Sheng Wu Gong Cheng Xue Bao; 2005 Mar; 21(2):284-8. PubMed ID: 16013491
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PEGylation markedly enhances the in vivo potency of recombinant human non-glycosylated erythropoietin: a comparison with glycosylated erythropoietin.
    Wang YJ; Hao SJ; Liu YD; Hu T; Zhang GF; Zhang X; Qi QS; Ma GH; Su ZG
    J Control Release; 2010 Aug; 145(3):306-13. PubMed ID: 20427020
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of Recombinant Methioninase for Cancer Treatment.
    Hoffman RM; Tan Y; Li S; Han Q; Yagi S; Takakura T; Takimoto A; Inagaki K; Kudou D
    Methods Mol Biol; 2019; 1866():107-131. PubMed ID: 30725412
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of PEGylation on biological therapies.
    Veronese FM; Mero A
    BioDrugs; 2008; 22(5):315-29. PubMed ID: 18778113
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interaction mechanism of mono-PEGylated proteins in electrostatic interaction chromatography.
    Abe M; Akbarzaderaleh P; Hamachi M; Yoshimoto N; Yamamoto S
    Biotechnol J; 2010 May; 5(5):477-83. PubMed ID: 20440716
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of bioactivity and pharmacokinetic characteristics of PEGylated P.pastoris-expressed erythropoietin.
    Maleki A; Najafabadi AR; Roohvand F; Shafiee A; Khanahmad H; Faghihi H; Hedayati MH; Tajerzadeh H
    Drug Deliv; 2011 Nov; 18(8):570-7. PubMed ID: 21892875
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pilot-scale production and characterization of PEGylated human FGF-21 analog.
    Ye X; Qi J; Yu D; Li S; Wu Q; Wu Y; Ren G; Han J; Li D
    J Biotechnol; 2016 Jun; 228():8-17. PubMed ID: 27109774
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coupling purification and on-column PEGylation of tumor necrosis factor alpha analogue.
    Milunović T; Kunstelj M; Fidler K; Anderluh G; Gaberc Porekar V
    Anal Biochem; 2012 Nov; 430(2):105-7. PubMed ID: 22922386
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro refolding of PEGylated lipase.
    Kim MY; Kwon JS; Kim HJ; Lee EK
    J Biotechnol; 2007 Aug; 131(2):177-9. PubMed ID: 17683821
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of strong anion-exchangers for the purification of a PEGylated protein.
    Pabst TM; Buckley JJ; Ramasubramanyan N; Hunter AK
    J Chromatogr A; 2007 Apr; 1147(2):172-82. PubMed ID: 17346720
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Site-specific PEGylation of hemoglobin at Cys-93(beta): correlation between the colligative properties of the PEGylated protein and the length of the conjugated PEG chain.
    Manjula BN; Tsai A; Upadhya R; Perumalsamy K; Smith PK; Malavalli A; Vandegriff K; Winslow RM; Intaglietta M; Prabhakaran M; Friedman JM; Acharya AS
    Bioconjug Chem; 2003; 14(2):464-72. PubMed ID: 12643758
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polyethylene glycol conjugation of recombinant methioninase for cancer therapy.
    Tan Y; Sun X; Xu M; An Z; Tan X; Han Q; Miljkovic DA; Yang M; Hoffman RM
    Protein Expr Purif; 1998 Feb; 12(1):45-52. PubMed ID: 9473456
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.